Kiadis Pharma B.V. - Product Pipeline Review - 2012

Table of Contents
List of Tables
List of Figures
Kiadis Pharma B.V. Snapshot
Kiadis Pharma B.V. Overview
Key Information
Key Facts
Kiadis Pharma B.V. – Research and Development Overview
Key Therapeutic Areas
Kiadis Pharma B.V. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Kiadis Pharma B.V. – Pipeline Products Glance
Kiadis Pharma B.V. – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Kiadis Pharma B.V. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Kiadis Pharma B.V. – Drug Profiles
ATIR
Product Description
Mechanism of Action
R&D Progress
reviroc
Product Description
Mechanism of Action
R&D Progress
Rhitol
Product Description
Mechanism of Action
R&D Progress
Kiadis Pharma B.V. – Pipeline Products by Route of Administration
Kiadis Pharma B.V. – Recent Pipeline Updates
Kiadis Pharma B.V. - Dormant Projects
Kiadis Pharma B.V. – Locations And Subsidiaries
Head Office
Kiadis Pharma B.V., Recent Developments
Kiadis Pharma B.V.- Press Release
Nov 05, 2009: Promising Clinical Data From Kiadis Pharma's Lead Product ATIR Will Be Presented At The 51st American Society Of Hematology's (ASH) Annual Meeting
Apr 08, 2009: Kiadis Pharma Reports ATIR Clinical Data, Further Supporting Its Potential In Mismatched Bone Marrow Transplantations ATIR Data Presented At The Annual EBMT Presidential Symposium
Financial Deals Landscape
Kiadis Pharma B.V., Deals Summary
Kiadis Pharma B.V., Pharmaceuticals & Healthcare, Deal Details
Asset Transactions
Kiadis Pharma Acquires Research Assets From Hybrigenics
Venture Financing
Kiadis Pharma Secures $20.19 Million In Financing
Partnerships
Kiadis Pharma Enters Into An Agreement With University of Perugia
Kiadis Pharma Enters Into Co-Development With Julius-Maximilians University
Licensing Agreements
Kiadis Pharma Enters Into Licensing Agreement With Hospira For ATIR
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables

Kiadis Pharma B.V., Key Information
Kiadis Pharma B.V., Key Facts
Kiadis Pharma B.V. – Pipeline by Indication, 2012
Kiadis Pharma B.V. – Pipeline by Stage of Development, 2012
Kiadis Pharma B.V. – Monotherapy Products in Pipeline, 2012
Kiadis Pharma B.V. – Phase III, 2012
Kiadis Pharma B.V. – Phase II, 2012
Kiadis Pharma B.V. – Pipeline By Route of Administration, 2012
Kiadis Pharma B.V. – Recent Pipeline Updates, 2012
Kiadis Pharma B.V. - Dormant Developmental Projects,2012
Kiadis Pharma B.V., Deals Summary
Kiadis Pharma Acquires Research Assets From Hybrigenics
Kiadis Pharma Secures $20.19 Million In Financing
Kiadis Pharma Enters Into An Agreement With University of Perugia
Kiadis Pharma Enters Into Co-Development With Julius-Maximilians University
Kiadis Pharma Enters Into Licensing Agreement With Hospira For ATIR

List of Figures

Kiadis Pharma B.V. – Pipeline by Indication, 2012
Kiadis Pharma B.V. – Pipeline by Stage of Development, 2012
Kiadis Pharma B.V. – Monotherapy Products in Pipeline, 2012
Kiadis Pharma B.V. – Pipeline By Route of Administration, 2012 15